Altered dimer interface decreases stability in an amyloidogenic protein

被引:96
作者
Baden, Elizabeth M. [1 ]
Owen, Barbara A. L. [2 ,3 ]
Peterson, Francis C. [4 ]
Volkman, Brian F. [4 ]
Ramirez-Alvarado, Marina [1 ]
Thompson, James R.
机构
[1] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN 55905 USA
[4] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
关键词
D O I
10.1074/jbc.M705347200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloidoses are devastating and currently incurable diseases in which the process of amyloid formation causes fatal cellular and organ damage. The molecular mechanisms underlying amyloidoses are not well known. In this study, we address the structural basis of immunoglobulin light chain amyloidosis, which results from deposition of light chains produced by clonal plasma cells. We compare light chain amyloidosis protein AL-09 to its wild-type counterpart, the kappa I O18/O8 light chain germline. Crystallographic studies indicate that both proteins form dimers. However, AL-09 has an altered dimer interface that is rotated 90 from the kappa I O18/O8 dimer interface. The three non-conservative mutations in AL-09 are located within the dimer interface, consistent with their role in the decreased stability of this amyloidogenic protein. Moreover, AL-09 forms amyloid fibrils more quickly than kappa I O18/O8 in vitro. These results support the notion that the increased stability of the monomer and delayed fibril formation, together with a properly formed dimer, may be protective against amyloidogenesis. This could open a new direction into rational drug design for amyloidogenic proteins.
引用
收藏
页码:15853 / 15860
页数:8
相关论文
共 51 条
[1]   Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL) [J].
Abraham, RS ;
Geyer, SM ;
Price-Troska, TL ;
Allmer, C ;
Kyle, RA ;
Gertz, MA ;
Fonseca, R .
BLOOD, 2003, 101 (10) :3801-3808
[2]   EXCITED-STATE PROPERTIES OF THE INDOLE CHROMOPHORE - ELECTRONIC-TRANSITION MOMENT DIRECTIONS FROM LINEAR DICHROISM MEASUREMENTS - EFFECT OF METHYL AND METHOXY SUBSTITUENTS [J].
ALBINSSON, B ;
NORDEN, B .
JOURNAL OF PHYSICAL CHEMISTRY, 1992, 96 (15) :6204-6212
[3]  
Alim MA, 1999, CLIN EXP IMMUNOL, V118, P344
[4]   Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties [J].
Bourne, PC ;
Ramsland, PA ;
Shan, L ;
Fan, ZC ;
DeWitt, CR ;
Shultz, BB ;
Terzyan, SS ;
Moomaw, CR ;
Slaughter, CA ;
Guddat, LW ;
Edmundson, AB .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :815-823
[5]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[6]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[7]   Protein misfolding, evolution and disease [J].
Dobson, CM .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :329-332
[8]   Coot:: model-building tools for molecular graphics [J].
Emsley, P ;
Cowtan, K .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :2126-2132
[9]   MOLECULAR-STRUCTURE OF A DIMER COMPOSED OF VARIABLE PORTIONS OF BENCE-JONES PROTEIN REI REFINED AT 2.0-A RESOLUTION [J].
EPP, O ;
LATTMAN, EE ;
SCHIFFER, M ;
HUBER, R ;
PALM, W .
BIOCHEMISTRY, 1975, 14 (22) :4943-4952
[10]   Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9 [J].
Ferguson, N ;
Capaldi, AP ;
James, R ;
Kleanthous, C ;
Radford, SE .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 286 (05) :1597-1608